NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Guizhou Yibai Pharmaceutical Co. Ltd (SHG: 600594)
600594 Technical Analysis
4
As on 19th Aug 2025 600594 STOCK Price closed @ 4.59 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.73 & Buy for SHORT-TERM with Stoploss of 4.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
600594STOCK Price
Open | 4.20 | Change | Price | % |
High | 4.59 | 1 Day | 0.42 | 10.07 |
Low | 4.18 | 1 Week | 0.36 | 8.51 |
Close | 4.59 | 1 Month | 0.53 | 13.05 |
Volume | 42523093 | 1 Year | 0.10 | 2.23 |
52 Week High 4.91 | 52 Week Low 2.92 |
SHG China Most Active Stocks
600010 | 2.66 | -0.75% |
601162 | 5.63 | -2.93% |
601929 | 3.99 | -7.42% |
600705 | 3.47 | 0.29% |
600811 | 0.36 | -2.70% |
600208 | 5.54 | 3.75% |
600795 | 4.77 | 5.76% |
601989 | 5.10 | 1.80% |
601288 | 7.02 | 1.30% |
600601 | 7.63 | 2.69% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
600594 Daily Charts |
600594 Intraday Charts |
Whats New @ Bazaartrend |
600594 Free Analysis |
|
600594 Important Levels Intraday
RESISTANCE | 5.38 |
RESISTANCE | 5.13 |
RESISTANCE | 4.97 |
RESISTANCE | 4.81 |
SUPPORT | 4.37 |
SUPPORT | 4.21 |
SUPPORT | 4.05 |
SUPPORT | 3.80 |
600594 Forecast August 2025
4th UP Forecast | 6.84 |
3rd UP Forecast | 6.12 |
2nd UP Forecast | 5.67 |
1st UP Forecast | 5.23 |
1st DOWN Forecast | 3.95 |
2nd DOWN Forecast | 3.51 |
3rd DOWN Forecast | 3.06 |
4th DOWN Forecast | 2.34 |
600594 Weekly Forecast
4th UP Forecast | 5.44 |
3rd UP Forecast | 5.17 |
2nd UP Forecast | 5.00 |
1st UP Forecast | 4.83 |
1st DOWN Forecast | 4.35 |
2nd DOWN Forecast | 4.18 |
3rd DOWN Forecast | 4.01 |
4th DOWN Forecast | 3.74 |
600594 Forecast2025
4th UP Forecast | 8.79 |
3rd UP Forecast | 7.44 |
2nd UP Forecast | 6.61 |
1st UP Forecast | 5.78 |
1st DOWN Forecast | 3.4 |
2nd DOWN Forecast | 2.57 |
3rd DOWN Forecast | 1.74 |
4th DOWN Forecast | 0.39 |
Guizhou Yibai Pharmaceutical Co. Ltd ( SHG China Symbol : 600594 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
600594 Other Details
Segment | EQ | |
Market Capital | 4387275264.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
600594 Address
![]() |
600594 Latest News
600594 Business Profile
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China. Address: No. 220-1, Baiyun Avenue, Guiyang, China, 550008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service